Pharmaceuticals

Rising Vaccine Development Demand Fueling Growth in the Biopharmaceutical Excipients Market

March 18, 2026March 18, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Forecasted Market Value Of The Biopharmaceutical Excipients Market Across 2026–2030?

The biopharmaceutical excipients market size has shown robust growth recently. It is anticipated to expand from $3.27 billion in 2025 to $3.57 billion in 2026, achieving a compound annual growth rate (CAGR) of 9.2%. The historical growth of this market is attributable to the rise in biologic drug approvals, the early acceptance of protein stabilizers, an increase in injectable formulations, the broadening of vaccine development, and progress in formulation science.

The biopharmaceutical excipients market is projected to experience substantial expansion in the coming years. This market is forecast to reach $5.04 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.0%. Key factors contributing to this growth during the forecast period include the escalating complexity of biologic formulations, a surging demand for products with extended shelf lives, the broadening application of cell and gene therapies, an enhanced regulatory emphasis on excipient safety, and increased investments in sophisticated drug delivery systems. Significant trends anticipated in this period encompass a heightened demand for high-purity biologic excipients, the expanding utilization of multifunctional formulation components, the development of excipients specifically for cell and gene therapies, a concentrated effort on stability-improving compounds, and greater customization of excipient solutions.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=30214&type=smp

Which Market Drivers Are Supporting The Expansion Of The Biopharmaceutical Excipients Market?

The expanding requirement for vaccine creation is anticipated to drive growth in the biopharmaceutical excipients market. Vaccine development encompasses the creation and formulation of immunizations designed to prevent infectious diseases and enhance public health, relying on superior excipients to guarantee the stability, effectiveness, and safety of vaccine products. This escalating need for vaccine development originates from a worldwide focus on averting infectious diseases, strengthening public health preparedness, and accelerating research to provide quicker and more potent immunization solutions. Biopharmaceutical excipients play a vital role in vaccine formulations by stabilizing antigens, improving solubility, and maintaining integrity throughout storage and distribution. For illustration, in 2025, data from the Centers for Disease Control and Prevention, a US-based national public health agency, indicated that adolescent vaccination coverage for critical vaccines such as tetanus, diphtheria, and acellular pertussis rose from 89.9% in 2022 to 91.3% in 2024. Furthermore, meningococcal conjugate vaccine coverage increased from 88.6% to 90.1%, and human papillomavirus vaccine coverage (=2 doses) saw substantial growth from 76.0% to 92.6% during the same period. Thus, the rising demand for vaccine development is propelling the expansion of the biopharmaceutical excipients market.

What Segmentation Levels Are Considered In The Biopharmaceutical Excipients Market?

The biopharmaceutical excipients market covered in this report is segmented –

1) By Product Types: Binders, Coatings, Diluents, Disintegrants, Lubricants And Glidants, Polyols, Preservatives, Solubilizers And Surfactants Or Emulsifiers, Suspending And Viscosity Agents

2) By Type Of Biologics: Antibodies, Vaccines, Cell Therapies, Other Biologics

3) By Functionality: Fillers And Diluents, Binders, Suspending And Viscosity Agents, Flavouring Agents And Sweeteners, Coating Agents, Colourants, Disintegrants, Lubricants And Glidants, Preservatives

4) By Application: Injectable Formulations, Oral Formulations, Topical Formulations, Transdermal Formulations, Cell and Gene Therapy

5) By End Users: Biopharmaceutical Companies And Pharmaceutical Companies, Contract Manufacturers, Research Institutes

Subsegments:

1) By Binders: Starch Binders, Cellulose Binders, Synthetic Binders, Natural Polymer Binders

2) By Coatings: Film Coatings, Sugar Coatings, Enteric Coatings, Polymer Coatings

3) By Diluents: Lactose, Microcrystalline Cellulose, Starch, Mannitol

4) By Disintegrants: Crosslinked Cellulose, Starch Derivatives, Crospovidone, Sodium Starch Glycolate

5) By Lubricants And Glidants: Magnesium Stearate, Stearic Acid, Talc, Silicon Dioxide

6) By Polyols: Sorbitol, Mannitol, Glycerol, Xylitol

7) By Preservatives: Parabens, Benzoates, Sorbates, Phenols

8) By Solubilizers And Surfactants Or Emulsifiers: Polysorbates, Polyethylene Glycol, Lecithin, Sodium Lauryl Sulfate

9) By Suspending And Viscosity Agents: Cellulose Derivatives, Xanthan Gum, Guar Gum, Carbomers

What Trends Are Projected To Affect The Biopharmaceutical Excipients Market?

Leading companies in the biopharmaceutical excipients market are prioritizing technological advancements, such as ultra-high purity surfactants, to enhance protein stability, prevent degradation, and support regulatory compliance in injectable formulations. Ultra-high purity surfactants are highly refined surface-active agents characterized by minimal impurities and a consistent composition, specifically designed to ensure stability, safety, and performance in sensitive pharmaceutical and biopharmaceutical formulations. For instance, in September 2025, Evonik Industries AG, a Germany-based chemicals company, unveiled MaxiPure Polysorbate 80, tailored for injectable and biopharmaceutical applications. This excipient is engineered with an oleic acid content exceeding ninety-eight percent, demonstrates exceptional clarity, and fully complies with European Pharmacopoeia, United States Pharmacopoeia, Japanese Pharmacopoeia, and Chinese Pharmacopoeia standards. It addresses crucial issues related to protein stability, prevents oxidative degradation, facilitates consistent solubilization of hydrophobic active pharmaceutical ingredients, and boosts formulation reliability. By integrating this excipient, Evonik enables pharmaceutical and biopharmaceutical companies to efficiently develop complex biologics and injectable therapies while ensuring safety and compliance.

Which Leading Firms Are Contributing To The Growth Of The Biopharmaceutical Excipients Market?

Major companies operating in the biopharmaceutical excipients market are The Archer-Daniels-Midland Company, BASF SE, The Dow Chemical Company, Mitsubishi Chemical Group Corporation, Novo Nordisk A/S, Associated British Foods plc, Merck KGaA, Asahi Kasei Corporation, Evonik Industries AG, Kerry Group plc, Wacker Chemie AG, Clariant AG, Shin-Etsu Chemical Co. Ltd., Roquette Frères, IMCD Group N.V., Croda International Plc, Ashland Global Holdings Inc., NOF Corporation, Colorcon Limited, J. Rettenmaier & Söhne GmbH + Co. KG, Spectrum Chemical Manufacturing Corporation, BioSpectra Inc., Sigachi Industries Limited, DFE Pharma, FUJIFILM Toyama Chemical Co. Ltd, Kirsch Pharma GmbH, Meggle Group GmbH, InVitria Inc., BOC Sciences Inc.

Read the full biopharmaceutical excipients market report here:

https://www.thebusinessresearchcompany.com/report/global-biopharmaceutical-excipients-market-report

How Is The Biopharmaceutical Excipients Market Distributed Across Key Geographic Regions?

North America was the largest region in the biopharmaceutical excipients market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biopharmaceutical excipients market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Biopharmaceutical Excipients Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=30214&type=smp

Browse Through More Reports Similar to the Global Biopharmaceutical Excipients Market 2026, By The Business Research Company

Pharmaceutical Excipient Market Report 2026

https://www.thebusinessresearchcompany.com/report/pharmaceutical-excipient-global-market-report

Organic Pharmaceutical Excipients Market Report 2026

https://www.thebusinessresearchcompany.com/report/organic-pharmaceutical-excipients-global-market-report

Nutraceutical Excipients Market Report 2026

https://www.thebusinessresearchcompany.com/report/nutraceutical-excipients-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795